Cell Impact AB Share Price Swiss Exchange
Equities
CI.B
SE0005003217
Industrial Machinery & Equipment
End-of-day quote
Other stock markets
|
||
- SEK | - |
09:21am | Cell Impact Adds Sealing as A New Part of Production Process | CI |
14/05 | Cell Impact AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 91.53M 8.66M 723M | Sales 2023 | 47.66M 4.51M 376M | Capitalization | 133M 12.59M 1.05B |
---|---|---|---|---|---|
Net income 2022 | -104M -9.84M -821M | Net income 2023 | -121M -11.44M -955M | EV / Sales 2022 | 7.76 x |
Net cash position 2022 | 120M 11.35M 947M | Net cash position 2023 | 57.14M 5.4M 451M | EV / Sales 2023 | 1.59 x |
P/E ratio 2022 |
-7.96
x | P/E ratio 2023 |
-0.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.6% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vallin
CEO | Chief Executive Officer | 47 | 01/21/01 |
Human Resources Officer | 52 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 01/22/01 | |
Mats Franzén
CHM | Chairman | 55 | 01/23/01 |
1st Jan change | Capi. | |
---|---|---|
+62.82% | 3.81B | |
-11.09% | 1.8B | |
-13.11% | 1.71B | |
-14.61% | 1.6B | |
-8.84% | 1.49B | |
+76.04% | 1.5B | |
+27.77% | 1.4B | |
-6.95% | 1.35B | |
-2.94% | 1.09B |
- Stock Market
- Equities
- CI Stock
- CI.B Stock